BiomX Raises $24 Million in Series A Funding to Develop Microbiome Therapeutics

Funds will be used for advancing Company's novel therapeutic pipeline and enhancing its unique microbiome modulation platform technologies NESS ZIONA, Israel, May 15, 2017 -- (Healthcare Sales & Marketing Network) -- BiomX Ltd., a leading microbiome th... Biopharmaceuticals, Venture Capital BiomX, microbiome, microbiome therapeutics
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news